Global Landmarks to Glow in Teal, Green, and Pink: #LightUpMBC 2026 Mobilizes to Transform the Narrative of Metastatic Breast Cancer
NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a global movement is preparing to shift the spotlight from the traditional "pink" narrative toward the starker, more urgent reality of those living with Stage 4 disease. On October 13, 2026, National Metastatic Breast Cancer (MBC) Awareness Day, the #LightUpMBC campaign will see more than 325 landmarks across 50 U.S. states and 20 countries illuminate in a symbolic display of teal, green, and pink.
The initiative, spearheaded by METAvivor Research and Support, aims to bridge the gap between awareness and action, raising critical funds for the only form of breast cancer that is currently terminal. With an estimated 42,670 Americans expected to die from the disease this year alone—averaging 117 deaths per day—the campaign serves as both a memorial for lives lost and a beacon of hope for those currently navigating the complexities of a metastatic diagnosis.
Main Facts: A Global Illumination for a Local Crisis
The #LightUpMBC campaign is defined by its visual scale and its singular focus on research. Unlike broad awareness campaigns that prioritize early detection and "finishing" treatment, #LightUpMBC centers on the reality that for Stage 4 patients, treatment never ends.
The Visual Movement
On the evening of October 13, major architectural icons will change their lighting schemes to the MBC awareness colors:
- Teal: Representing healing and community.
- Green: Symbolizing the triumph of spring over winter, or the renewal of life.
- Pink: Acknowledging the breast cancer origin of the disease.
Participating landmarks include the One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, and the Ness Bridge in Inverness, Scotland. The reach extends to the Mactan-Cebu Airport in the Philippines, illustrating the global nature of the MBC crisis.
The Digital Experience
Complementing the physical illuminations is #LightUpMBC Live, a virtual broadcast streaming at 8 p.m. ET / 5 p.m. PT. Hosted by creator Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway’s Kara Lindsay, the program features a blend of patient testimonials, scientific updates, and high-profile musical performances. The event is designed to educate the public on the biological differences between early-stage and metastatic disease while raising the funds necessary to find a cure.
Chronology: From a Single Bridge to a Global Phenomenon
The history of #LightUpMBC is a testament to the power of individual advocacy in the face of tragedy. The movement traces its roots back to 2017, inspired by the late Jessica Moore.
2017: The First Light
Jessica Moore was diagnosed with metastatic breast cancer at the age of 32. During her treatment, she noted a profound disconnect between the "pink ribbon" culture of October and the reality of her terminal diagnosis. Her simple wish was to see one local landmark lit in the MBC colors to acknowledge those for whom "survivorship" is a lifelong medical regimen rather than a milestone. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up for MBC.
2018–2022: Rapid Expansion
Following Jessica’s passing at the age of 36, her best friend, Laura Inahara, founded the #LightUpMBC campaign to honor her legacy. What began as a local tribute quickly resonated with the MBC community worldwide. By 2020, despite the global pandemic, the campaign moved into the digital space with the first #LightUpMBC Live stream, allowing patients isolated by health concerns to participate in a collective moment of solidarity.
2023–2026: Institutional Integration
By 2026, #LightUpMBC has become the flagship fundraising event for METAvivor. To date, the campaign has raised over $2.7 million. The current iteration involves a sophisticated logistical network of "Landmark Leads"—volunteers across the globe who petition city councils and building managers to participate in the October 13 illumination.
Supporting Data: The Statistical Reality of Stage 4
The urgency of the #LightUpMBC campaign is underscored by data from the National Cancer Institute’s SEER program and other oncology research bodies.
The Mortality Gap
While five-year survival rates for localized breast cancer have reached nearly 99%, the outlook for metastatic disease remains challenging.
- Daily Toll: Approximately 117 people in the U.S. die every day from MBC.
- Total Deaths: The projected 42,670 deaths in 2026 represent a plateau that advocates argue can only be broken through dedicated Stage 4 research.
- Funding Disparity: Historically, less than 7% of total breast cancer research funding is directed toward metastatic disease, despite it being the cause of nearly all breast cancer deaths.
The Biological Challenge
MBC occurs when cancer cells break away from the primary tumor in the breast and travel through the circulatory or lymphatic system to form new tumors in distant organs.
- Common Sites: The bones, liver, lungs, and brain are the most frequent sites of metastasis.
- Treatment Resistance: A defining characteristic of MBC is its ability to evolve. Even when a treatment is successful for months or years, the cancer often develops resistance, necessitating a perpetual "ladder" of different therapies.
- De Novo vs. Recurrence: While many are diagnosed after an initial early-stage bout, a significant portion of patients are "de novo," meaning they are diagnosed at Stage 4 from their very first screening.
Official Responses: Leadership and Advocacy
Leaders within the MBC community emphasize that #LightUpMBC is more than a light show; it is a demand for scientific equity.
Dr. Kelly Shanahan, METAvivor Board President, provides a unique perspective as both a physician and a patient. Diagnosed in 2013, Shanahan has outlived many of the initial statistics associated with the disease.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," said Dr. Shanahan. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days as we look for ways to make this disease a manageable chronic condition rather than a death sentence."
Laura Inahara, Founder of #LightUpMBC, reflected on the emotional weight of the campaign’s growth.
"Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love," Inahara stated. "It has raised over $2.7 million for critical research, but more importantly, it has taught patients how to advocate for themselves in a world that often wants to look away from the terminal side of cancer."
Tami Eagle Bowling, Campaign Director and Host, highlighted the inclusivity of the live event.
"We are bringing together Tony Award winners, world-class scientists, and the patients themselves. This isn’t just about grief; it’s about the vibrancy of the community that is fighting to stay alive," Bowling said.
Implications: Shifting the Paradigm of Breast Cancer Advocacy
The continued success and expansion of #LightUpMBC have significant implications for the future of oncology and patient advocacy.
Redefining "Awareness"
For decades, October has been synonymous with "Pinktober," a month focused heavily on mammograms and early detection. While these are vital, the #LightUpMBC movement is successfully forcing a secondary conversation. It highlights the "forgotten" population—those for whom early detection either didn’t happen or didn’t prevent the spread of the disease. This shift is crucial for reducing the stigma and isolation often felt by Stage 4 patients.
The METAvivor Funding Model
The campaign serves as a primary engine for METAvivor’s unique funding model. As a 501(c)(3) nonprofit, METAvivor ensures that 100% of net proceeds from #LightUpMBC go directly to research grants. These grants are awarded through a rigorous peer-review process that includes both scientific experts and patient advocates, ensuring that the research funded has the highest potential for immediate patient impact.
A Path to Survivability
The ultimate goal of the campaign is to transform MBC from a terminal illness into a "survivable condition with a good quality of life," similar to how HIV/AIDS was transitioned from a death sentence to a manageable chronic illness in the 1990s. By funding research specifically targeted at why cancer spreads and how it becomes resistant to drugs, METAvivor and the #LightUpMBC campaign are building the scientific infrastructure necessary for this transition.
As the lights go up on October 13, the message from the MBC community is clear: awareness is the first step, but research is the only way home.
About METAvivor:
METAvivor Research and Support Inc. is an organization dedicated to the specific needs of the metastatic breast cancer community. It is the only national organization that exclusively funds MBC research. For more information, visit www.metavivor.org.
About #LightUpMBC:
